Vanillin serves as a potential substitute for chemical chelator desferal in iron-overloaded mice

Eur J Pharmacol. 2023 Dec 5:960:176153. doi: 10.1016/j.ejphar.2023.176153. Epub 2023 Oct 30.

Abstract

Purpose: Iron toxicity occurs under iron-overloaded settings, such as a high iron diet and blood transfusion, and damages important organs. Vanillin has been proven to have potential iron chelation capability. Given the negative effects of commonly used iron chelators like deferoxamine (DFO), we sought to examine the iron chelation potency of vanillin and evaluate its potential effect in the treatment of iron overload-related disorders.

Methods: 42 male NMRI mice were prepared for this purpose, and except for the negative control group, iron overload conditions were generated in them by injecting iron. Then normal saline (as a control), vanillin, and DFO (n = 7) were subsequently given to iron-overloaded mice. In the following, the activity of antioxidant enzymes catalase and superoxide dismutase were measured in the blood serum, brain, kidney, spleen, lung, and liver tissues of mice. Furthermore, the level of lipid peroxidation was determined by measuring the amount of malondialdehyde. Also, Perl's and H&E staining were used to examine the physiopathology changes of tissues.

Findings: Vanillin, a natural antioxidant compound, outperformed deferoxamine, a chemical iron chelator. Along with a decrease in iron content, the activity of catalase and superoxide dismutase enhanced in the iron-overloaded groups that were treated with vanillin. The level of lipid peroxidation was also declined in the iron-overloaded mice receiving vanillin.

Conclusion: Vanillin can be used as a suitable substitute for chemical chelators with fewer side effects and equivalent efficiency. We encourage the use of this compound as a natural iron chelator following performing additional safety and efficacy studies.

Keywords: Deferoxamine; Iron overload; Pathophysiology; Vanillin.

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Catalase
  • Deferoxamine* / pharmacology
  • Iron
  • Iron Chelating Agents / pharmacology
  • Iron Chelating Agents / therapeutic use
  • Iron Overload* / drug therapy
  • Iron Overload* / pathology
  • Male
  • Mice
  • Superoxide Dismutase

Substances

  • Deferoxamine
  • vanillin
  • Catalase
  • Antioxidants
  • Iron Chelating Agents
  • Iron
  • Superoxide Dismutase